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Abstract: Vocal cord dysfunction is an asthma mimic. Diagnosis of this condition requires 
a high index of suspicion if unnecessary treatments are to be avoided. We describe the 
findings from our case series of 62 patients (age range 18 to 90 years) in whom the diagno-
sis was confirmed. Our findings show low-dose amitriptyline to be very effective in 90% of 
cases, with rapid benefit for those patients whose symptoms had been present for less than 
12 months. This treatment, in conjunction with psycho-therapeutic and behavioral therapies 
may reduce unnecessary hospital admissions. Future studies may show whether this treatment 
regimen may reduce demands on the speech and language therapists.
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Introduction
Vocal cord dysfunction (VCD) is an asthma mimic, which may present in association 
with asthma or be misdiagnosed as asthma.1,2 The literature reports an average delay 
of 4 years to the correct diagnosis in such cases.3 There is a female predominance,4 
with quoted ratios of 40 female:1 male.5 81% of patients are Caucasian with a common 
age range of 14 to 60 years.
Diagnosis requires a high index of suspicion and the following factors may hold 
clues to determining a correct diagnosis:1,3,6
a)  Suspect if asthma suddenly deteriorates or becomes unresponsive to previous 
treatments.
b)  Attacks of wheezing worse by day, which may be surprisingly short lived.5
c)  Steroid “pseudo-resistance” is demonstrated; where patients previously responsive 
to steroids appear to no longer respond.
d)  Attacks that are provoked by exercise.5
e)  Pungent smells, hyperventilation, stress or cough may be precipitants of an attack 
of wheeze.7
The literature recognizes 3 patterns of VCD
1.  Exercise-induced VCD where symptoms are limited to exercise.
2.  Spontaneous VCD where there is a sudden onset of symptoms without exercise.
3.  Persistent VCD where adduction of the vocal cords in both inspiration and expiration 
is observed. This is usually associated with an emergency admission.
Observation or history taking may reveal an attack of sudden onset occurring spon-
taneously or with exercise and of a brief duration. There may be tightness in the throat, 
with a flexed neck during attacks. A change in voice quality, due to misuse of the vocal Journal of Asthma and Allergy 2009:2 106
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cords may be present. Attempts to measure lung function 
may show variable results, depending on the degree of vocal 
cord adduction during each measurement.8 If the vocal cord 
adduction is severe an intense audible stridor, which is 
predominantly inspiratory can be heard. This would suggest 
that persistent cord adduction is occurring. Asymptomatic 
periods may occur. Chest tightness and breathlessness on 
exertion, with a cough would suggest exercise-induced VCD. 
This often occurs at a set distance. These distances can be 
very short, sometimes 10 m. There may be a feeling of 
trapped mucus around the vocal cord area, resulting from 
the interruption of the normal mucociliary clearance due to 
cord adduction.
In normal movement of the vocal cords, there is inspiratory 
abduction (opening) followed by a brief expiratory phase 
adduction (closing) of 2 mm from the fully abducted position 
to generate physiological autoPEEP.6,9  This is the positive 
end expiratory pressure generated in part by the vocal cords 
to prevent early airway closure. The cords then open again 
for inspiration. Voluntary cord adduction in a sustained 
manner during inspiration is impossible in the healthy normal 
subject.6,7 Abnormal inspiratory vocal cord adduction may 
have pathological (cerebral) causes such as Arnold-Chiari 
malformation and cerebral aqueduct stenosis or even drug 
induced brain stem dysfunction. This has also been noted 
in motor neurone disease, myotonic disorders, Parkinson’s 
disease and laryngeal breathing dystonias.7
In non-organic VCD, inspiratory adduction of the anterior 
two-thirds of the cords can produce a diamond-shaped 
opening in the posterior segment.9 This can generate the 
pitch of wheeze similar to asthma, but the wheeze is loudest 
over the larynx and is usually audible.8 The chest x-ray is 
often normal, but some patients with persistent adduction 
can induce acute hyperinflation and use accessory muscles, 
if adduction is severe.1 Presentation to intensive treatment 
unit in status asthmaticus, even with a silent chest, has been 
described. Intubation often finds normal airway pressures 
and therefore extubation usually follows within a short 
time. In the acute setting of possible status asthmaticus, 
it is difficult to take a different course of action. Once 
recognized, it is appropriate for these patients to be treated 
with heliox (a mixture of oxygen 24% and helium) and light 
anxiolytics.1,7
The results of measured lung function are variable,3 with 
obstructive, restrictive or normal values appearing, depending 
upon the activity of the VCD. Arterial blood gases are usually 
normal, unless persistent adduction of the vocal cords occurs 
in which a silent chest may be produced.3,8
Failure to recognize the condition of VCD, leads to the 
prescription of unnecessary medication with associated 
adverse effects.1,2 Repeat admissions for what is a benign 
condition is undesirable and reinforces the undiagnosed 
problem.10
Physicians managing patients with VCD recognize the 
importance of psychological stresses on clinical symptoms.3,11 
VCD is associated with a high rate of co-morbid psychiatric 
disorders. One survey found that 73% of 95 patients with 
VCD had a psychiatric diagnosis.8,12,14 It has also been 
suggested that patients with this condition have an increased 
rate of childhood trauma or abuse.1,4,5
Treatment to relieve symptoms is recommended before 
attempting to deal with the psychological stress.8,9 Without 
this symptom relief, addressing psychological conditions can 
aggravate vocal cord dysfunction. Treatments to date include:4 
“panting” and other behavioral techniques to encourage 
abduction of the vocal cords,2,9 with such patient education 
performed by a speech and language therapist.7 Tranquillizers 
are also recommended.3 The literature describes variable 
resistance breathing systems which consists of facemasks 
with one-way valves to induce inspiratory drag.13 This reduces 
inspiratory stridor and gives psychological relief, which 
may reduce reinforcement of the attack and offer a solution. 
Historical treatments included tracheostomy.6 Botulinum 
injections have been proposed as a treatment, but no 
randomized controlled studies have yet been published.5,7
Examination of vocal cords in the absence of symptoms 
may show normal movements. However, in persistent VCD 
the vocal cord adduction may be seen at any time.7 Breathing 
is often reported by relatives to improve during sleep and 
to deteriorate when mental stress occurs. The condition 
itself, if unrecognized, leads to increased anxiety and a 
consequent increase in the VCD severity. Some patients may 
show more than one of the 3 patterns of VCD described. 
Without a high index of suspicion, the condition may be 
overlooked in asthmatics.4 A routine auscultation over the 
vocal cord area is a useful screen during acute admissions 
and outpatient reviews. It is especially indicated if asthma 
becomes worse or appears steroid unresponsive.10 Even 
B2 agonists can aggravate symptoms in individuals with 
VCD, a feature not noted frequently in true asthma attacks. 
During vocal cord inspection, if adduction of the cords is 
visible only in expiration, this must be interpreted with 
caution, as it is likely to be a physiological and adaptive 
mechanisms and not VCD.7 The paradoxical movements 
must be those of inspiratory adduction.6 If the flow volume 
loops are measured during an attack abnormalities will Journal of Asthma and Allergy 2009:2 107
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be demonstrated.2 Twenty-five percent of subjects may show 
variable but persistently abnormal loops. In these patients, 
extra thoracic obstruction must be excluded. Fifty percent 
of subjects can have VCD by exercise.5,7
It is important for the respiratory technician to print all 
flow-volume loops, as there is a risk that any loops of an 
unusual appearance, may be disregarded as an error and not be 
recognized as related to VCD. Flutter of the inspiratory loop 
and brief changes in the expiratory loop causing flattening 
(top hat effect) are described.1 From the flow volume loop, 
visible flattening of the inspiratory portion is seen and 
indicates upper airway obstruction, which could include 
other causes such as subglottic stenosis and vocal cord 
dysfunction. This makes inspection of the cords essential. 
From the flow-volume loop, if the maximum mid expiratory 
flow is divided by the maximum mid inspiratory flow and has 
a value of 1.5 this suggests vocal cord dysfunction.2
Method
The patients
The study describes 62 consecutive patients. Age range 18 
to 90 years (17 male/45 female) in whom VCD was suspected 
and confirmed. In 40%, previous stable asthma had been 
present but a change in clinical circumstances had occurred. 
This had taken the form of treatment resistance, or hospital 
admission for an asthma attack. Others were referred to 
outpatients with a new suspected asthma, which appeared 
unresponsive to their GP’s treatment.
History and physical findings
A history of asthma-like symptoms was sought and past asthma 
patterns established with spirometry and peak flows recorded. 
Skin tests for atopy were performed if atopic symptoms were 
present. Specific enquiry was made into possible symptoms 
of VCD. These included frequent attacks of audible wheezy 
noises (or stridor), occurring during exercise or associated 
with stress, or brief daytime attacks with or without recog-
nized triggers. Voice changes, throat tightness and a feeling 
of mucus adhering around the vocal cord area were enquired 
about. The limitation of exercise and the walking distance 
before symptoms occurred were established. A walking test 
was performed, so that observation and auscultation of the 
chest and vocal cord area could be performed.
Anxiety and assessment
Although a formal assessment of mood was not undertaken, 
recent life events were discussed, including enquires 
about any work stress or trauma that may have preceded 
the symptoms. Significant insomnia was found in 95% of 
confirmed cases.
Fiber-optic examination of the cords
This was undertaken for each case, with attempts to establish 
likely triggers before the examination. This would allow 
examination of the cords, followed by “a stress” to induce 
VCD. In a large number of cases the “stress” was through 
exercise, especially climbing stairs. In others cases, pungent 
smells, including perfume, brought by the patients to the fiber-
optic test were used as triggers. Many were induced by the 
lignocaine preparation for the fiber-optic examination and the 
anxiety associated with the investigation. Careful inspection 
of the cords for vocal cord disease, especially tumors and 
paralysis was as important as assessing movement. Two 
patients with vocal cord cancers were identified, and excluded 
from this study however this emphasized the importance 
of inspecting all cords. The cord movement was inspected 
during the induced wheeze/stridor when the patient was 
asked to take deep breaths in and out despite their condition. 
The inspiratory and expiratory phase of respiration was 
determined by a hand placed on the sternum, so that simul-
taneous cord inspection and the phase of respiration were 
accurately assessed. Adduction during the inspiratory phase 
was confirmation of vocal cord dysfunction. Acid reflux 
around the epiglottis and vocal cord area was also noted 
and treated if present.
Methacholine test
Patients with a significant history of asthma and vocal cord 
symptoms had a methacholine test to assess bronchial hyper-
reactivity, if it was doubtful that their inhaled therapy was 
optimal.
Amitriptyline treatment
Tricyclic antidepressants have no previously described benefit 
in VCD. However, the authors had noted that a low dose of 
amitriptline for night sedation, often led to a rapid improve-
ment in the symptoms of VCD. The starting doses were low, 
10 mg 2 to 3 hours before bed, which were increased by 
10 mg each week until adequate sleep was induced. Many 
of the patients in this series were already on long term 
selective serotonin reuptake inhibitors (SSRIs). If this was 
the case, the SSRI was maintained and amitriptyline was 
added to it. Patients with protracted symptoms with treat-
ment resistance and anxiety affecting their quality of life 
were referred to liaison psychiatry. During the course of our 
investigations, if the patients were judged to have previously Journal of Asthma and Allergy 2009:2 108
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undiagnosed anxiety related or depressive illness, they were 
referred to the local liaison psychiatry service for further 
management.
referral to speech therapy
There is a high prevalence of abnormal voice quality in 
vocal cord dysfunction15 and behavioral treatment offered by 
voice specialist speech and language therapists (SLT, speech 
pathologists) is an encouraging option.16 Significant 
subjective and objective improvements in symptoms have 
been recorded in studies of the characteristics of laryngeal 
respiratory disorders and their treatment, via a combination 
of medical management and respiratory retraining.17,18
In the study, 43 patients were referred to the SLT. Those 
who had not previously had their vocal cords examined were 
seen for nasoendoscopy with the ear-nose-throat (ENT) 
surgeon in the joint ENT/SLT clinic for further assessment 
of laryngeal structure and function.
Therapeutic approaches were predicated on explanatory 
discussion of laryngeal mechanisms and vocal cord 
function in normal respiration and phonation. The causes 
and effects of abnormal/paradoxical vocal cord movement 
were discussed in relation to patients’ presenting symptoms. 
Possible chemical triggers and psychosocial aspects were 
also discussed. Patients benefited from reassurance that 
VCD is caused by central chemo-reflex changes, which can 
be reversible via behavioral techniques.
Specific therapeutic techniques aimed to encourage vocal 
cord abduction and to divert attention away from the larynx 
included:
•  Sip and swallow routines.
•  Pursed lip breathing.
•  Blowing against finger held to the lips.
•  Nasal only breathing.
•  Abdominal breathing.
The success of treatment depended heavily upon patients’ 
response to the opportunity to discuss and understand their 
symptoms and to bring them under voluntary control.
Patients who did not benefit from voice therapy were 
those who, at the time of treatment, were unable to meet the 
challenge of changing maladaptive respiratory behaviors.
Results
Table 1 shows the patients’ demographics. All patients had 
VCD confirmed at fiber-optic examination. Two patients had 
vocal cord tumors and are excluded from further analysis.
In the case series, previous asthma was higher in women 
(64%) than men (31%). All patients described significant 
insomnia and awareness of anxiety symptoms (including 
panic) which was twice as common in women (72%) than 
men (31%). Life events and work stress affected up to 40% 
of the series with 65% of women already prescribed an 
antidepressant.
Most patients’ symptoms were intermittent or exercise-
induced but 16% were more persistent and appeared a feature 
in older women with chronic asthma and anxiety. Amitripty-
line had beneficial effects on insomnia and improved reported 
anxiety particularly in men.
The response to amitriptyline and the mean dose required 
is shown in Table 2.
There was an identical approach to treatment in all 
patients. This involved initially starting a 10 mg dose of 
amitriptyline 2 hours before bed for the first week. Patients 
were instructed to increase the dose by 10 mg each week 
(maximum dose 75 mg) until sleep was restored. Once sleep 
improved, VCD appeared to show rapid improvement in 
Table 1 Patient demographics: the case series and the percentage 
with prior asthma, insomnia, and anxiety at diagnosis
  Male Female
Number of subjects 17 45
Average age (range) 54 (19–80) 48 (8–90)
Previous asthma 31% 64%
% with insomnia 95% 91%
% aware of anxiety 31% 72%
% with traumatic life event/work stress 41% 32%
% on antidepressant treatment 
at presentation
12% 65%
% with spontaneous and persistent 
VCD symptoms
7%  16% 
Abbreviation:   VCD, vocal cord dysfunction.
Table 2 The response to amitriptyline: responses and doses of 
amitriptyline required and its benefit, treatment failures and side-
effects
  Male Female
Number of subjects 17 45
% responding to amitriptyline  
with cessation of    VCD
94% 82%
Mean dose required (range) 20 mg (10–40) 20 mg (10–75)
% with improved insomnia 100% 100%
% with improved anxiety 90% 96%
Treatment failures where   VCD  
did not cease
6% 18%
intolerance due to side effects Nil 2 (dry mouth)
Abbreviation:  VCD, vocal cord dysfunction.Journal of Asthma and Allergy 2009:2 109
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most patients. We learnt that inspection of the cords was 
necessary before treatment, as many patients’ symptoms 
had resolved from the start of treatment and before the 
fiber-optic examination just 5 to 7 days later.
The response to amitriptyline was higher in men (94%) 
than women (82%), but insomnia improved in all patients. 
Anxiety also improved in 90% of patients. Eight patients 
who had long-standing persistent VCD, which had not 
been recognized early, were difficult clinical management 
problems. While they did show some improvement with 
amitriptyline, the VCD did not cease even though its severity 
did diminish. In these patients help with liaison psychiatry 
was necessary.
The response to amitriptyline was sufficient on a mean 
dose of 20 mg, which is low enough to not have significant 
side-effects or interaction with other ongoing antidepres-
sant therapy. Some patients did require a full dose of 75 mg 
for benefit, but this was the minority. We found that many 
patients once improved, were able to reduce the dose of 
amitriptyline within a few weeks to 10 mg without relapse, 
and continued this dose for the minimum 6-month period 
suggested by us. Re-enforcing the nature of the condition 
and demonstrating the paradoxical movement of the cords 
at fiber-optic examination did prove helpful in allowing the 
patient to take charge of the condition with advice from 
the SLT.
Adverse effects of amitriptyline  
and duration of treatment
The initial dose was low (10 mg), in order to avoid 
over sedation and a dry mouth. The treatment period 
was 3 to 6 months to establish new vocal cord patterns and 
break old habits. The mean dose required was 20 mg at 
bedtime, but the range of doses used is shown in Table 2.
Discussion
This case series demonstrated a reproducible benefit of 
low-dose amitriptyline in patients with VCD. The mean 
dose required was 20 mg taken 2 to 3 hours before bed. 
In the majority of patients this resulted in symptom resolution 
within 1 week. At outpatient review at 4 weeks there was 
resolution of the problem in most cases with reduced anxiety 
and greatly improved length and quality of sleep. The high 
percentage of patients already taking SSRIs indicated that 
the presence of emotional problems had been recognized, 
but these drugs did not appear to influence VCD. The addition 
of low-dose amitriptyline, without withdrawal of the SSRI, 
did not lead to therapeutic problems. It became clear from 
the series that resolution was quickest in those with a shorter 
duration of VCD (less than 3 months), where symptoms 
could abate in 1 to 7 days regardless of prior asthma. This 
emphasizes the importance issue of inspection of the cords 
before commencing treatment and early recognition to 
confirm the diagnosis before starting treatment. In patients 
with the condition for 3 to 12 months prior to diagnosis, 
resolution was likely by 4 weeks. There were few treatment 
failures, but when they did occur the patients were generally 
female and older (60 years) with co-morbid asthma and 
psychological problems. Spontaneous attacks and exercise-
induced vocal cord symptoms appeared to resolve well with 
a longer duration of amitriptyline
Insomnia, which was significant, was present in over 90% 
of all cases of proven VCD and appeared to be associated 
with the condition. Questioning patients can frequently define 
an initiating stress in their life, particularly in those without 
prior difficult asthma.
Referral to speech and language therapy is extremely 
helpful, but resources are limited and regional waiting times 
vary. Therefore the treatment with amitriptyline could serve 
to indicate more precisely those patients who would benefit 
more from such therapy. This series demonstrated that the 
age range of patients is greater than that published in the 
literature, with cases occurring into the 90th year often 
following traumatic events.
Our findings suggest that low-dose amitriptyline (10 to 
20 mg) could be a cost effective treatment in patients with 
VCD. Initial treatment, even in mild cases needs to be for 
3 to 6 months. This should re-establish a healthy vocal cord 
pattern. In other cases of more persistent VCD, indefinite 
prophylactic treatment may be warranted with the aim of 
improving quality of life and avoiding unnecessary hospital 
admissions and treatments.
This case series is the first to identify the use of amitrip-
tyline in VCD, but clearly this is not a randomized controlled 
trial and did not formally measure psychiatric morbidities in 
each patient. The severity of asthma was assessed, but not by 
a standardized protocol.
Although the study indicated that low-dose amitriptyline 
is associated with an improvement in the symptoms of 
VCD, the mechanism of action is unknown. Amitriptyline 
was prescribed in doses that are generally sub therapeutic 
for anxiety and depressive disorders, yet sleep benefit with 
a secondary effect on the cords was observed. It may act 
directly on the nervous control of the cords. Low-dose 
amitriptyline is commonly used by the rheumatologists 
to treat neck spasms and headaches. The drug is known Journal of Asthma and Allergy 2009:2
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to have several sites of action in the nervous system, one 
of which may include muscle relaxation. VCD has been 
described in 2 case reports after prolonged stimulation of 
the vagal nerve by implanted devices. This suggested that 
the vagus may have a role in the condition. Clinical benefit 
has been described in 6 patients with exercise-induced VCD 
who inhaled the anticholinergic drug ipratropium prior to 
exercise.19,20 It is known that amitriptyline has anticholin-
ergic affects also.
The findings would support the need for a randomized 
controlled trial to fully assess an active and control arm. 
This could include stratification of the VCD to intermittent, 
frequent and severe. It could also assess fully, anxiety levels, 
asthma status, life events and outcomes in the active and 
control groups.
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